As of 5 Jul 2026, Jubilant Ingrevia share price is ₹678.95. The stock opened at ₹676.95, compared to its previous close of ₹670.80. During today's trading session, Jubilant Ingrevia share price moved in the range of ₹665.65 to ₹688.75, with an average price of ₹677.20 for the day. Looking at its last 52-week, the stock has touched a low of ₹537.30 and a high of ₹851.80. On the performance front, Jubilant Ingrevia share price has declined by 6.51% over the last six months and is down 12.91% on a year-on-year basis.
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Pidilite Industries | 1,63,368.00 | 66.11 | 15.08 | 22.61% | 0.03 | 29.97% | 104.79 | 1.34% | 1.18 | 23.43 |
| SRF | 82,964.90 | 39.50 | 5.16 | 13.76% | 0.28 | 13.78% | 5.73 | 0.37% | 0.78 | 58.18 |
| Linde India | 61,370.10 | 111.80 | 14.38 | 12.87% | 0.02 | 17.16% | 495.72 | 0.17% | 0.56 | 64.59 |
| Gujarat Fluorochemicals | 43,636.80 | 76.03 | 5.58 | 7.30% | 0.22 | 8.93% | 647.24 | 0.08% | 0.59 | 61.69 |
| Godrej Industries | 40,773.60 | 16.91 | 3.65 | 11.10% | 6.25 | 9.34% | 52.53 | 0.00% | 0.73 | 1.81 |
| Navin Fluorine | 39,211.90 | 59.10 | 9.87 | 16.69% | 0.03 | 18.14% | 714.61 | 0.20% | 0.60 | 96.03 |
| Himadri Speciality Chemicals | 33,428.40 | 29.64 | 4.73 | 17.92% | 0.12 | 22.34% | 4.82 | 0.18% | 0.89 | 15.05 |
| Deepak Nitrite | 21,438.30 | 38.93 | 3.67 | 9.43% | 0.02 | 10.74% | 235.74 | 0.48% | 0.79 | 13.85 |
| Deepak Fertilizers & Petr | 20,963.10 | 28.38 | 3.06 | 10.77% | 0.23 | 10.76% | 290.01 | 0.60% | 0.44 | 21.33 |
| Atul | 19,031.20 | 27.61 | 3.06 | 10.90% | 0.00 | 14.31% | 2,056.91 | 0.46% | 0.89 | 202.11 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹4,177.62 | ₹4,135.80 | ₹4,772.69 | ₹4,949.36 |
| Other Income | ₹37.82 | ₹35.30 | ₹33.37 | ₹31.49 |
| Total Revenue | ₹4,215.43 | ₹4,171.10 | ₹4,806.06 | ₹4,980.85 |
| Total Expenses | ₹3,871.79 | ₹3,903.51 | ₹4,369.31 | ₹4,271.86 |
| Profit Before Tax | ₹343.62 | ₹267.61 | ₹436.71 | ₹708.94 |
| Tax | ₹92.44 | ₹84.72 | ₹129.22 | ₹232.23 |
| Profit After Tax | ₹251.18 | ₹182.89 | ₹307.50 | ₹476.71 |
| EPS - Basic | ₹15.89 | ₹11.56 | ₹19.34 | ₹29.98 |
| EPS - Diluted | ₹15.84 | ₹11.55 | ₹19.33 | ₹29.97 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹343.62 | ₹267.61 | ₹436.71 | ₹708.94 |
| Income before WC changes | ₹564.88 | ₹470.12 | ₹584.99 | ₹882.06 |
| Change in Assets | -₹39.53 | ₹38.02 | -₹11.84 | -₹404.04 |
| Change in Liabilities | ₹62.33 | -₹32.15 | -₹33.31 | ₹102.83 |
| Change in WC | ₹22.79 | ₹5.87 | -₹45.15 | -₹301.22 |
| Cash flow from Operations | ₹508.10 | ₹429.98 | ₹462.46 | ₹452.74 |
| Cash flow from Investing | -₹392.82 | -₹568.78 | -₹471.89 | -₹71.86 |
| Cash flow from Financing | -₹128.76 | ₹144.13 | ₹41.60 | -₹417.75 |
| Total Cash Flow | -₹9.43 | ₹6.06 | ₹35.12 | -₹35.73 |
| Cash (Start of the year) | ₹78.78 | ₹72.73 | ₹37.61 | ₹73.34 |
| Cash (End of the year) | ₹69.36 | ₹78.78 | ₹72.73 | ₹37.61 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹3,178.54 | ₹2,951.99 | ₹2,440.88 | ₹2,032.58 |
| Current Assets | ₹1,853.23 | ₹1,779.90 | ₹1,818.00 | ₹1,764.57 |
| Total Assets | ₹5,031.77 | ₹4,731.89 | ₹4,258.88 | ₹3,797.15 |
| Current Liabilities | ₹1,401.00 | ₹1,286.08 | ₹1,179.58 | ₹1,052.78 |
| Net Current Asset | ₹452.23 | ₹493.83 | ₹638.43 | ₹711.79 |
| Non-Current Liabilities | ₹703.69 | ₹708.34 | ₹413.07 | ₹311.25 |
| Equity Capital | ₹2,927.08 | ₹2,737.47 | ₹2,666.23 | ₹2,433.12 |
| Total Equity & Liabilities | ₹5,031.77 | ₹4,731.89 | ₹4,258.88 | ₹3,797.15 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹3,941.22 | ₹3,987.25 | ₹4,559.58 | ₹4,860.42 |
| Other Income | ₹81.01 | ₹35.52 | ₹31.03 | ₹28.82 |
| Total Revenue | ₹4,022.23 | ₹4,022.77 | ₹4,590.60 | ₹4,889.24 |
| Total Expenses | ₹3,678.87 | ₹3,783.77 | ₹4,223.02 | ₹4,213.77 |
| Profit Before Tax | ₹343.37 | ₹239.00 | ₹367.58 | ₹675.47 |
| Tax | ₹79.94 | ₹76.55 | ₹114.17 | ₹223.22 |
| Profit After Tax | ₹263.43 | ₹162.45 | ₹253.41 | ₹452.25 |
| EPS - Basic | ₹16.54 | ₹10.20 | ₹15.91 | ₹28.39 |
| EPS - Diluted | ₹16.54 | ₹10.20 | ₹15.91 | ₹28.39 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹343.37 | ₹239.00 | ₹367.58 | ₹675.47 |
| Income before WC changes | ₹519.46 | ₹449.88 | ₹527.19 | ₹854.22 |
| Change in Assets | -₹45.93 | ₹40.39 | ₹6.57 | -₹351.52 |
| Change in Liabilities | ₹41.39 | -₹63.39 | -₹16.46 | ₹195.22 |
| Change in WC | -₹4.54 | -₹23.00 | -₹9.89 | -₹156.30 |
| Cash flow from Operations | ₹441.34 | ₹393.65 | ₹445.64 | ₹586.80 |
| Cash flow from Investing | -₹210.55 | -₹463.67 | -₹475.28 | -₹220.76 |
| Cash flow from Financing | -₹208.42 | ₹64.07 | ₹32.80 | -₹410.23 |
| Total Cash Flow | ₹22.37 | -₹5.96 | ₹3.16 | -₹44.19 |
| Cash (Start of the year) | ₹18.70 | ₹24.66 | ₹21.50 | ₹65.69 |
| Cash (End of the year) | ₹41.07 | ₹18.70 | ₹24.66 | ₹21.50 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹2,863.62 | ₹2,797.32 | ₹2,461.21 | ₹2,067.24 |
| Current Assets | ₹1,657.10 | ₹1,543.08 | ₹1,597.19 | ₹1,584.89 |
| Total Assets | ₹4,520.72 | ₹4,340.40 | ₹4,058.39 | ₹3,652.13 |
| Current Liabilities | ₹1,413.64 | ₹1,388.09 | ₹1,269.40 | ₹1,130.97 |
| Net Current Asset | ₹243.46 | ₹154.99 | ₹327.79 | ₹453.92 |
| Non-Current Liabilities | ₹666.21 | ₹705.25 | ₹630.42 | ₹538.11 |
| Equity Capital | ₹2,440.88 | ₹2,247.06 | ₹2,158.57 | ₹1,983.05 |
| Total Equity & Liabilities | ₹4,520.72 | ₹4,340.40 | ₹4,058.39 | ₹3,652.13 |
Jubilant Ingrevia Limited is a vertically integrated provider of life sciences products and solutions. Its segments include Specialty chemicals, Nutrition & Health solutions and Chemical intermediates. The Specialty Chemicals segment includes bio-pyridine & bio-picolines, fine chemicals, agro chemicals, custom development and manufacturing organization, and microbial control solutions. The Nutrition & Health solutions segment includes nutrition and health ingredients and animal and human nutrition health solutions. The Chemical Intermediates segment includes acetyls and specialty ethanol. In agro chemicals, it offers value-added derivatives, derived from specialty building blocks such as pyridine, picoline and diketene derivatives. This sub-segment includes insecticides, herbicides and fungicides. Its product portfolio includes vital nutritional ingredients, including Vitamin B3, Vitamin B4, Picolinates, and premix formulations designed for both animal and human nutrition.
Jubilant Ingrevia share price is ₹678.95 as on 03 Jul, 2026, 15:41 IST.
In the last 1 year, Jubilant Ingrevia delivered a return of -12.91%. The Jubilant Ingrevia share price hit a high of ₹851.80 and low of ₹537.30.
The Mutual Fund Shareholding in Jubilant Ingrevia was 22.21% at the end of Mar 2026.
The 52-week high and low of Jubilant Ingrevia share is ₹851.80 and ₹537.30 as of 03 Jul, 2026.
The market capitalisation of Jubilant Ingrevia is ₹10,690.20 Crores as on 03 Jul, 2026.
The stock symbol of Jubilant Ingrevia is JUBLINGREA on the NSE, 543271 on the BSE, and the ISIN is INE0BY001018.
Jubilant Ingrevia shares closed yesterday at ₹670.80 on NSE & ₹671.15 on BSE
To buy Jubilant Ingrevia shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
No, shares of Jubilant Ingrevia or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Jubilant Ingrevia shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
The PE and PB ratio of Jubilant Ingrevia is 38.46 and 3.42 respectively, as on 03 Jul, 2026, 15:41 IST.